About Papyrus Therapeutics
Papyrus Therapeutics is a company based in West Chester (United States) founded in 2016 by Hani Gabra and Paul Blake. It operates as a B2B. Papyrus Therapeutics offers products and services including Extracellular Tumor Suppressor Therapies. Papyrus Therapeutics operates in a competitive market with competitors including ChemoTech, Nativis, IGEA and RanD, among others.
- Headquarter West Chester, United States
- Founders Hani Gabra, Paul Blake
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Papyrus Therapeutics
Papyrus Therapeutics offers a comprehensive portfolio of products and services, including Extracellular Tumor Suppressor Therapies.
Therapies aimed at suppressing tumors in multiple cancers through research.
Funding Insights of Papyrus Therapeutics
Detailed funding history for Papyrus Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Papyrus Therapeutics
Investment portfolio details for Papyrus Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Papyrus Therapeutics
Detailed financials for Papyrus Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Papyrus Therapeutics Comparisons
Peer comparison for Papyrus Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Papyrus Therapeutics
Papyrus Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChemoTech, Nativis, IGEA and RanD, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of electroporation devices for the treatment of cancer
|
|
| Locked | Locked | Locked |
Developer of a therapeutic device for the treatment of cancer
|
|
| Locked | Locked | Locked |
Orthopedic medical devices to promote reparative osteogenesis and joint protection
|
|
| Locked | Locked | Locked |
Medical devices for surgical oncology are developed using extracorporeal technologies.
|
Detailed competitors of Papyrus Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Papyrus Therapeutics
Complete news archive for Papyrus Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Papyrus Therapeutics
Papyrus Therapeutics was founded in 2016.
Papyrus Therapeutics is headquartered in West Chester, United States. It is registered at West Chester, Pennsylvania, United States.
Paul Blake is the current CEO of Papyrus Therapeutics. They have also founded this company.
Papyrus Therapeutics specializes in creating extracellular tumor suppressor therapies to treat multiple types of cancers, focusing on innovative scientific research and development. The company operates from West Chester, PA, in North America, and London, UK, in Europe, engaging in oncology advancements. They aim to contribute to medical treatments by addressing tumor suppression, though specific clients or partnerships are not detailed.
Papyrus Therapeutics offers Extracellular Tumor Suppressor Therapies.